120MO Inupadenant Combined with Chemotherapy in Patients with Non-Squamous NSCLC Progressing on or after Immune Checkpoint Inhibitor Therapy: Results from Dose-Finding Part of the A2A-005 Trial

K. Cuppens, G. Lo Russo,O.J. Juan Vidal, E. Felip, M.C. Areses Manrique, A. Chiappori, E. Govaerts,P.K. Cheema,L. Greillier, L. Toschi, E. Schaefer, M. Clouseau, C. Martinoli, H. Shehade, N. Byrne, M. Fox, M. Rossetti, O. De Henau, S. Ross,S. Peters

Immuno-Oncology and Technology（2024）

引用 0|浏览0